{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T12:08:58Z","timestamp":1785240538165,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009730","name":"Universidade Federal de Ouro Preto","doi-asserted-by":"publisher","award":["082017080"],"award-info":[{"award-number":["082017080"]}],"id":[{"id":"10.13039\/501100009730","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["APQ-02638-17"],"award-info":[{"award-number":["APQ-02638-17"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["APQ-01373-14"],"award-info":[{"award-number":["APQ-01373-14"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["APQ 02577-18"],"award-info":[{"award-number":["APQ 02577-18"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["APQ-02556-18"],"award-info":[{"award-number":["APQ-02556-18"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["435224\/2018-2"],"award-info":[{"award-number":["435224\/2018-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.molimm.2021.11.011","type":"journal-article","created":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T16:40:15Z","timestamp":1637426415000},"page":"70-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Comparative evaluation of meglumine antimoniate encapsulated in a mixture of conventional and PEGylated liposomes and immunotherapy using an anti-canine IL-10 receptor-blocking monoclonal antibody on canine visceral leishmaniasis"],"prefix":"10.1016","volume":"141","author":[{"given":"Jamille Mirelle de Oliveira","family":"Cardoso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rory Cristiane Fortes de","family":"Brito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Augusto Siqueira","family":"Mathias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levi Eduardo Soares","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Filipe Pereira","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1463-6168","authenticated-orcid":false,"given":"Thais Lopes Valentim Di Paschoale","family":"Ostolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9lida Monteiro de","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme Santos","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3783-5717","authenticated-orcid":false,"given":"Fr\u00e9d\u00e9ric","family":"Fr\u00e9zard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8705-7357","authenticated-orcid":false,"given":"Rodrigo Dian de Oliveira","family":"Aguiar-Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno Mendes","family":"Roatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre Barbosa","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2021.11.011_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2021.11.011_bib0010","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1517\/17425247.2014.932347","article-title":"Mixed formulation of conventional and pegylated liposomes as a novel drug delivery strategy for improved treatment of visceral leishmaniasis","volume":"11","author":"Azevedo","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.molimm.2021.11.011_bib0015","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-3024.2006.00840.x","article-title":"Immunology of canine leishmaniasis","volume":"062","author":"Barbi\u00e9ri","year":"2006","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.molimm.2021.11.011_bib0020","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1128\/CVI.00456-09","article-title":"Immunologic indicators of clinical progression during canine leishmania infantum infection","volume":"17","author":"Boggiatto","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.molimm.2021.11.011_bib0025","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.molimm.2021.06.014","article-title":"IL-10 receptor blockade controls the in vitro infectivity of Leishmania infantum and promotes a Th1 activation in PBMC of dogs with visceral leishmaniasis","volume":"137","author":"Cardoso","year":"2021","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2021.11.011_bib0030","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.vetimm.2008.10.310","article-title":"Cytokine profiles in canine visceral leishmaniasis","volume":"128","author":"Carrillo","year":"2008","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.molimm.2021.11.011_bib0035","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3389\/fimmu.2019.00670","article-title":"Cytokines: key determinants of resistance or disease progression in visceral leishmaniasis: opportunities for novel diagnostics and immunotherapy","volume":"10","author":"Dayakar","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2021.11.011_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0002729","article-title":"Use of a recombinant cysteine proteinase from Leishmania (Leishmania) infantum chagasifor the immunotherapy of canine visceral leishmaniasis","volume":"8","author":"Ferreira","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.molimm.2021.11.011_bib0045","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.3390\/molecules14072317","article-title":"Pentavalent antimonials: new perspectives for old drugs","volume":"14","author":"Fr\u00e9zard","year":"2009","journal-title":"Molecules"},{"key":"10.1016\/j.molimm.2021.11.011_bib0050","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.vetpar.2019.05.006","article-title":"Canine visceral leishmaniasis biomarkers and their employment in vaccines","volume":"271","author":"Giunchetti","year":"2019","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.molimm.2021.11.011_bib0055","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3389\/fcimb.2019.00427","article-title":"An overview of immunotherapeutic approaches against canine visceral leishmaniasis: what has been tested on dogs and a new perspective on improving treatment efficacy","volume":"9","author":"Gon\u00e7alves","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.molimm.2021.11.011_bib0060","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0165-2427(02)00128-9","article-title":"Evaluation of a specific immunochemotherapy for the treatment of canine visceral leishmaniasis","volume":"88","author":"Guarga","year":"2002","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.molimm.2021.11.011_bib0065","article-title":"Leishmaniasis: complexity at the host \u2013 pathogen interface","volume":"9","author":"Kaye","year":"2011","journal-title":"Nat. Publ. Gr."},{"key":"10.1016\/j.molimm.2021.11.011_bib0070","doi-asserted-by":"crossref","first-page":"901","DOI":"10.2217\/fmb.14.43","article-title":"Immunity to visceral leishmaniasis: implications for immunotherapy","volume":"9","author":"Khadem","year":"2014","journal-title":"Future Microbiol."},{"key":"10.1016\/j.molimm.2021.11.011_bib0075","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.vetpar.2014.08.022","article-title":"Immunological profile of resistance and susceptibility in naturally infected dogs by Leishmania infantum","volume":"205","author":"Leal","year":"2014","journal-title":"Vet. Parasitol."},{"issue":"1687\u20139686","key":"10.1016\/j.molimm.2021.11.011_bib0080","first-page":"541571","article-title":"Cytokine and phenotypic cell profiles of leishmania infantum infection in the dog","author":"Maia","year":"2012","journal-title":"J. Trop. Med."},{"key":"10.1016\/j.molimm.2021.11.011_bib0085","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.vetpar.2006.06.028","article-title":"Leishmania DNA load and cytokine expression levels in asymptomatic naturally infected dogs","volume":"142","author":"Manna","year":"2006","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.molimm.2021.11.011_bib0090","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s13071-015-0896-0","article-title":"Long-term follow-up of dogs with leishmaniosis treated with meglumine antimoniate plus allopurinol versus miltefosine plus allopurinol","volume":"8","author":"Manna","year":"2015","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.molimm.2021.11.011_bib0095","first-page":"510","article-title":"Detection of intracellular IFN-\u03b3 and IL-4 cytokines in CD4+ and CD8+ T cells in the peripheral blood of dogs naturally infected with Leishmania infantum","volume":"38","author":"Matralis","year":"2016"},{"key":"10.1016\/j.molimm.2021.11.011_bib0100","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1179\/1364859411Y.0000000027","article-title":"Evaluation of TNF-\u03b1, IL-4, and IL-10 and parasite density in spleen and liver of L. (L.) chagasi naturally infected dogs","volume":"105","author":"Michelin","year":"2011","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.molimm.2021.11.011_bib0105","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.pt.2017.05.005","article-title":"Novel areas for prevention and control of canine leishmaniosis","volume":"33","author":"Mir\u00f3","year":"2017","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.molimm.2021.11.011_bib0110","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0165-2427(99)00096-3","article-title":"The immune response and PBMC subsets in canine visceral leishmaniasis before, and after, chemotherapy","volume":"71","author":"Moreno","year":"1999","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.molimm.2021.11.011_bib0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trstmh.2009.07.026","article-title":"Immunological stimulation for the treatment of leishmaniasis: a modality worthy of serious consideration","volume":"104","author":"Musa","year":"2010","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.molimm.2021.11.011_bib0120","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-3164.2005.00460.x","article-title":"Treatment of canine old world visceral leishmaniasis: a systematic review","volume":"16","author":"Noli","year":"2005","journal-title":"Vet. Dermatol."},{"key":"10.1016\/j.molimm.2021.11.011_bib0125","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1017\/S0031182009006155","article-title":"Cytokine expression in dogs with natural Leishmania infantum infection","volume":"136","author":"Panaro","year":"2009","journal-title":"Parasitology"},{"key":"10.1016\/j.molimm.2021.11.011_bib0130","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/iai.62.1.229-235.1994","article-title":"Cellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania infantum","volume":"62","author":"Pinelli","year":"1994","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2021.11.011_bib0135","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1086\/319869","article-title":"Tissue cytokine responses in canine visceral leishmaniasis","volume":"183","author":"Quinnell","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.molimm.2021.11.011_bib0140","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.rvsc.2005.09.011","article-title":"Parasite density and impaired biochemical\/hematological status are associated with severe clinical aspects of canine visceral leishmaniasis","volume":"81","author":"Reis","year":"2006","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.molimm.2021.11.011_bib0145","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.vetimm.2008.10.307","article-title":"Systemic and compartmentalized immune response in canine visceral leishmaniasis","volume":"128","author":"Reis","year":"2009","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.molimm.2021.11.011_bib0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.00962-17","article-title":"Mixed formulation of conventional and pegylated meglumine antimoniate- containing liposomes reduces inflammatory process and parasite burden in Leishmania infantum-infected BALB\/c mice","volume":"61","author":"Reis","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.molimm.2021.11.011_bib0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/3296893","article-title":"Canine leishmaniasis: an overview of the current status and strategies for control","volume":"2018","author":"Ribeiro","year":"2018","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.molimm.2021.11.011_bib0160","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3389\/fimmu.2017.00217","article-title":"A vaccine therapy for canine visceral leishmaniasis promoted significant improvement of clinical and immune status with reduction in parasite burden","volume":"8","author":"Roatt","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2021.11.011_bib0165","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.actatropica.2013.04.005","article-title":"Improvement in clinical signs and cellular immunity of dogs with visceral leishmaniasis using the immunomodulator P-MAPA","volume":"127","author":"Santiago","year":"2013","journal-title":"Acta Trop."},{"key":"10.1016\/j.molimm.2021.11.011_bib0170","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2019.00362","article-title":"Meglumine antimoniate and miltefosine combined with allopurinol sustain pro-inflammatory immune environments during canine leishmaniosis treatment","volume":"6","author":"Santos","year":"2019","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.molimm.2021.11.011_bib0175","first-page":"1","article-title":"Therapeutic efficacy of a mixed formulation of conventional and PEGylated liposomes containing meglumine antimoniate, combined with allopurinol, in dogs naturally infected with Leishmania infantum","volume":"64","author":"Santos","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.molimm.2021.11.011_bib0180","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1128\/AAC.00208-12","article-title":"Efficacy of combined therapy with liposome-encapsulated meglumine antimoniate and allopurinol in treatment of canine visceral leishmaniasis","volume":"56","author":"Silva","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.molimm.2021.11.011_bib0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetpar.2009.05.022","article-title":"Directions for the diagnosis, clinical staging, treatment and prevention of canine leishmaniosis","volume":"165","author":"Solano-Gallego","year":"2009","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.molimm.2021.11.011_bib0190","first-page":"1","article-title":"Early reduction of Leishmania infantum - specific antibodies and blood parasitemia during treatment in dogs with moderate or severe disease","volume":"235","author":"Solano-Gallego","year":"2016","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.molimm.2021.11.011_bib0195","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/516526","article-title":"Response to interferon-g plus pentavalent antimony in Indian visceral leishmaniasis","author":"Sundar","year":"1997","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.molimm.2021.11.011_bib0200","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.prevetmed.2016.08.006","article-title":"Correlations between peripheral parasite load and common clinical and laboratory alterations in dogs with visceral leishmaniasis","volume":"132","author":"Torrecilha","year":"2016","journal-title":"Prev. Vet. Med."},{"key":"10.1016\/j.molimm.2021.11.011_bib0205","doi-asserted-by":"crossref","first-page":"7","DOI":"10.7705\/biomedica.v34i1.2153","article-title":"Ethical and epidemiological dilemmas in the treatment of dogs for visceral leishmaniasis in Latin America","volume":"34","author":"Travi","year":"2014","journal-title":"Biomedica"},{"key":"10.1016\/j.molimm.2021.11.011_bib0210","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1016\/j.vaccine.2010.02.089","article-title":"Treatment of canine visceral leishmaniasis by the vaccine Leish-111f+MPL-SE","volume":"28","author":"Trigo","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2021.11.011_bib0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018873","article-title":"Influence of clinical status and parasite load on erythropoiesis and leucopoiesis in dogs naturally infected with Leishmania (Leishmania) chagasi","volume":"6","author":"Tr\u00f3pia de Abreu","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2021.11.011_bib0220","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.vetpar.2018.03.010","article-title":"Therapeutic vaccine of killed Leishmania amazonensis plus saponin reduced parasite burden in dogs naturally infected with Leishmania infantum","volume":"254","author":"Viana","year":"2018","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.molimm.2021.11.011_bib0225","series-title":"Integrating Neglected Tropical Diseases Into Global Health and Development: Fourth WHO Report on Neglected Tropical Diseases","author":"WHO","year":"2017"}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589021003217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589021003217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T19:51:21Z","timestamp":1777492281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589021003217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":45,"alternative-id":["S0161589021003217"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2021.11.011","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative evaluation of meglumine antimoniate encapsulated in a mixture of conventional and PEGylated liposomes and immunotherapy using an anti-canine IL-10 receptor-blocking monoclonal antibody on canine visceral leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2021.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}